| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/14653240902806986 |
| P698 | PubMed publication ID | 19333801 |
| P2093 | author name string | Cheng Zhang | |
| Chang Zhou | |||
| Chen Zhang | |||
| Ji-Jun Teng | |||
| Ren-Liang Zhao | |||
| Yu-Qiang Song | |||
| P433 | issue | 3 | |
| P921 | main subject | cerebrospinal fluid | Q54196 |
| amyotrophic lateral sclerosis | Q206901 | ||
| P304 | page(s) | 299-306 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Cytotherapy | Q5201399 |
| P1476 | title | Multiple administrations of human marrow stromal cells through cerebrospinal fluid prolong survival in a transgenic mouse model of amyotrophic lateral sclerosis | |
| P478 | volume | 11 |
| Q35598216 | A safety study on intrathecal delivery of autologous mesenchymal stromal cells in rabbits directly supporting Phase I human trials. |
| Q44704967 | Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis |
| Q38062482 | Autologous stem cells in neurology: is there a future? |
| Q36908657 | Cell based therapy in Parkinsonism |
| Q39946077 | Cell-Based Neurorestorotherapy in Amyotrophic Lateral Sclerosis - Scientific Truth should Rely on Facts, but Not Conjecture |
| Q38210852 | Developments in treatments for amyotrophic lateral sclerosis via intracerebroventricular or intrathecal delivery |
| Q40628478 | Human marrow stromal cells reduce microglial activation to protect motor neurons in a transgenic mouse model of amyotrophic lateral sclerosis |
| Q34321059 | Intracerebroventricular injection of encapsulated human mesenchymal cells producing glucagon-like peptide 1 prolongs survival in a mouse model of ALS. |
| Q41864591 | Intrathecal delivery of mesenchymal stromal cells protects the structure of altered perineuronal nets in SOD1 rats and amends the course of ALS. |
| Q34182540 | Longitudinal tracking of human fetal cells labeled with super paramagnetic iron oxide nanoparticles in the brain of mice with motor neuron disease |
| Q64111179 | Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis? |
| Q26999783 | Mesenchymal stem cell transplantation in multiple sclerosis |
| Q48729092 | Multiple systemic transplantations of human amniotic mesenchymal stem cells exert therapeutic effects in an ALS mouse model |
| Q44326907 | Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model |
| Q49961729 | Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis |
| Q35665302 | Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis |
| Q50759645 | Repeated versus single transplantation of mesenchymal stem cells in carbon tetrachloride-induced liver injury in mice. |
| Q33616384 | Roles of vascular endothelial growth factor in amyotrophic lateral sclerosis |
| Q48450832 | Stem cell therapy in multiple sclerosis: a future perspective |
| Q26995278 | Stem cell transplantation for motor neuron disease: current approaches and future perspectives |
| Q38341972 | Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact? |
| Q39471822 | Suppression of Etk/Bmx protects against ischemic brain injury |
| Q47136854 | Transplantation of Mesenchymal Stromal Cells in Patients With Amyotrophic Lateral Sclerosis: Results of Phase I/IIa Clinical Trial |
| Q36939729 | Use of a Human Artificial Chromosome for Delivering Trophic Factors in a Rodent Model of Amyotrophic Lateral Sclerosis |
Search more.